Nursing facility
Dignity Health
Dignity Health was paid $6.31M by Medicaid between Jan 2018 and Nov 2020, across 104 billing codes. Its largest line is 0450, Emergency room services — 25% of everything it billed.
33Billing provider infoDIGNITY HEALTH
CAMARILLO, CA 93010
CAMARILLO, CA 93010
33aNPI1194877332assigned 01/17/2007
33bProvider typeSkilled Nursing Facility
28Total paid$6.31M
24GClaims101,502
24DCodes billed104
24AFirst – last monthJan 2018 – Nov 2020
Compared with peers
Next to other Skilled Nursing Facility providers in California
Rank by total paid#14 of 547
Median peer was paid$73K
This provider vs. median86×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MORISSETTE, DANIEL controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 38,374 | $2.06M | |
| 2019 | 38,471 | $2.54M | |
| 2020 | 24,657 | $1.72M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 25% | 16,745 | 14,856 | $1.58M |
| A4649 | Surgical supply; miscellaneous | 25% | 4,019 | 3,450 | $1.57M |
| J3490 | Unclassified drugs | 14% | 5,704 | 4,255 | $862K |
| 36415 | Collection of venous blood by venipuncture | 9.4% | 5,008 | 4,377 | $595K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3.7% | 927 | 908 | $231K |
| 80053 | Comprehensive metabolic panel | 3.1% | 6,639 | 5,913 | $193K |
| 71046 | Radiologic examination, chest; 2 views | 1.5% | 1,734 | 1,707 | $95K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1.4% | 790 | 739 | $90K |
| 87081 | 1.3% | 723 | 716 | $83K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.1% | 896 | 887 | $67K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1.0% | 408 | 397 | $66K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1.0% | 1,323 | 1,030 | $64K |
92 more codes
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,568 | $46K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 590 | $46K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,051 | $42K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 474 | $39K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 952 | $39K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,071 | $39K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 725 | $37K |
| 81001 | <1% | 3,148 | $33K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,542 | $33K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 477 | $30K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,790 | $27K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 168 | $26K |
| J2060 | Injection, lorazepam, 2 mg | <1% | 241 | $23K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 986 | $23K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 450 | $21K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 165 | $19K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 244 | $18K |
| 87077 | <1% | 346 | $17K | |
| 73630 | <1% | 194 | $17K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 678 | $15K |
| 81002 | <1% | 737 | $15K | |
| 81025 | <1% | 1,306 | $15K | |
| 99283 | Emergency room visit (moderate) | <1% | 400 | $13K |
| 82962 | <1% | 833 | $13K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 707 | $12K |
| 99284 | Emergency room visit (serious) | <1% | 483 | $11K |
| 81000 | <1% | 651 | $10K | |
| 11043 | <1% | 49 | $9K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,246 | $8K |
| 73562 | <1% | 94 | $8K | |
| 73130 | <1% | 67 | $8K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,492 | $8K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,347 | $7K |
| 73030 | <1% | 73 | $6K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,401 | $6K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 754 | $6K |
| 99285 | Emergency room visit (most serious) | <1% | 315 | $6K |
| 73610 | <1% | 62 | $4K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 493 | $4K |
| 86850 | <1% | 95 | $4K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 742 | $4K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,622 | $4K |
| 0710 | <1% | 77 | $3K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 102 | $3K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 148 | $3K |
| 73110 | <1% | 40 | $3K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 151 | $3K |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 13 | $3K |
| 90715 | <1% | 12 | $2K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 35 | $2K |
| 76830 | Ultrasound, transvaginal | <1% | 80 | $2K |
| 84702 | <1% | 643 | $2K | |
| 86900 | <1% | 198 | $2K | |
| 83880 | <1% | 1,068 | $2K | |
| 72100 | <1% | 13 | $1K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 16 | $1K |
| 84703 | <1% | 898 | $1K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 12 | $1K |
| 0761 | <1% | 29 | $1K | |
| 0250 | <1% | 14 | $1K | |
| 87070 | <1% | 27 | $1K | |
| 83690 | <1% | 3,130 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 337 | $990.35 |
| 84484 | <1% | 1,916 | $984.87 | |
| 85610 | <1% | 932 | $849.53 | |
| 85379 | <1% | 303 | $820.79 | |
| 83605 | <1% | 817 | $736.87 | |
| 87186 | <1% | 298 | $631.67 | |
| A9270 | Non-covered item or service | <1% | 598 | $530.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 13 | $518.13 |
| 87634 | <1% | 269 | $493.58 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 82 | $451.07 |
| 85730 | <1% | 702 | $422.74 | |
| 87040 | <1% | 549 | $378.29 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 12 | $337.68 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 94 | $280.93 |
| 96376 | <1% | 333 | $275.40 | |
| 83735 | <1% | 338 | $161.40 | |
| 82550 | <1% | 685 | $137.33 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 13 | $87.97 |
| 86703 | <1% | 105 | $84.57 | |
| 85027 | <1% | 173 | $84.31 | |
| 86140 | <1% | 57 | $80.38 | |
| 87205 | <1% | 37 | $60.44 | |
| 86901 | <1% | 199 | $29.03 | |
| 94760 | <1% | 37 | $20.43 | |
| 80076 | <1% | 27 | $7.32 | |
| 85007 | <1% | 75 | $7.12 | |
| 82553 | 0% | 12 | $0.00 | |
| 87807 | 0% | 14 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 12 | $0.00 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMORISSETTE, DANIEL (CHIEF FINANCIAL OFFICER)
Parent organizationDIGNITY HEALTH
| Provider | Location | Paid |
|---|---|---|
| Dignity Health | San Bernardino, CA | $133.09M |
| Dignity Health | Phoenix, AZ | $126.19M |
| Dignity Health | Bakersfield, CA | $109.22M |
| Dignity Health | Merced, CA | $106.54M |
| Dignity Health | Carmichael, CA | $97.28M |
| Dignity Health | Oxnard, CA | $96.24M |
| Dignity Health | Redding, CA | $92.21M |
| Dignity Health | Long Beach, CA | $59.98M |
| Dignity Health | Sacramento, CA | $45.52M |
| Dignity Health | Folsom, CA | $45.14M |
| Dignity Health | Red Bluff, CA | $39.92M |
| Dignity Health | Santa Cruz, CA | $33.59M |
| Dignity Health | Gilbert, AZ | $28.49M |
| Dignity Health | Glendale, AZ | $26.30M |
| Dignity Health | Henderson, NV | $18.73M |
| Dignity Health | Mount Shasta, CA | $15.62M |
| Dignity Health | Henderson, NV | $8.52M |
| Dignity Health | Las Vegas, NV | $7.93M |
| Dignity Health | Santa Maria, CA | $5.79M |
| Dignity Health | Corning, CA | $3.24M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.